QIAGEN: Q4 2018 EPS beat despite sales miss. Very cautious start to 2019 | BUY | EUR37,5
QIAGEN - BUY | EUR37,5(+17%)Q4 2018 EPS beat despite sales miss. Very cautious start to 2019
Q4 EPS beat despite weak sales
FY18 sales in the low-end of the guidance, slight EPS beat
Cautious FY19, even more cautious Q1 19 guidance
Reiterate Buy: strong fundamentals and ramp-up throughout 2019
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.